Cindy Rosenwald

The Food and Drug Administration (FDA) has indicated a proactive stance toward establishing a regulatory framework for Cannabidiol (CBD) while continuing to monitor kratom closely. Kimberlee Trzeciak, FDA Deputy Commissioner for Policy, Legislation and International Affairs, announced the agency...